Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.
[Ultrahigh field MRI in context of neurological diseases.]
Teriflunomide : a novel oral treatment for relapsing multiple sclerosis.
Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.
Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions.
Audiological evidence of therapeutic effect of steroid treatment in neuromyelitis optica with hearing loss.
Relationship between Optical Coherence Tomography and Electrophysiology of the Visual Pathway in Non-Optic Neuritis Eyes of Multiple Sclerosis Patients.
Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy.
Sunshine and multiple sclerosis.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort.
Paracrine Effects of Mesenchymal Stem Cells-Conditioned Medium on Microglial Cytokines Expression and Nitric Oxide Production.
The possible efficacy of artichoke in fluconazole related hepatotoxicity.
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
New extension study data with Novartis drug Gilenya® shows patients successfully treated for up to 7 years in relapsing MS
Upper limb functional electrical stimulation devices and their man-machine interfaces.
Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis.
Significant increase in the prevalence of multiple sclerosis in iran in 2011.
ALCAM - Novel multiple sclerosis locus interfering with HLA-DRB1*1501.
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.
Ion Channels in Neurological Disorders.
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »